Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Clinical Cancer Research|2019Cited by 58
Supplementary Legend from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Unknown|2023Cited by 0
Supplementary Figure 7 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Unknown|2023Cited by 0